FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2519463942> ?p ?o ?g. }

• W2519463942 endingPage "73472" @default.
• W2519463942 startingPage "73462" @default.
• W2519463942 abstract "// Jie Luo 1, * , Xiaoxia Huang 2, * , Yali Li 1 , Yang Li 1 , Xueqin Xu 1 , Yan Gao 1 , Ruoshi Shi 1 , Wanjun Yao 1 , Juying Liu 1 , Changbin Ke 1 1 Institute of Anesthesiology & Pain (IAP), PET-CT, Institute of Anesthesiology and Department of Anesthesiology, Taihe Hospital, Hubei University of Medicine, Shiyan City, 442000, Hubei Province, China 2 Department of Nephrology, Taihe Hospital, Hubei University of Medicine, Shiyan City, 442000, Hubei Province, China * These authors have contributed equally to this work Correspondence to: Changbin Ke, email: Changbinke@gmail.com Keywords: bone cancer pain, spinal cord, GPR30, excitatory transmission, inhibitory transmission Received: June 13, 2016      Accepted: August 26, 2016      Published: September 06, 2016 ABSTRACT Cancer induced bone pain is a very complicated clinical pain states that has proven difficult to be treated effectively due to poorly understand of underlying mechanism, but bone cancer pain (BCP) seems to be enhanced by a state of spinal sensitization. In the present study, we showed that carcinoma tibia implantation induced notable pain sensitization and up-regulation of G-protein-coupled estrogen receptor (GPR30) in the spinal cord of rats which was reversed by GPR30 knockdown. Further studies indicated that upregulation of GPR30 induced by cancer implantation resulted in a select loss of γ-aminobutyric acid-ergic (GABAergic) neurons and functionally diminished the inhibitory transmission due to reduce expression of the vesicular GABA transporter (VGAT). GPR30 contributed to spinal cord disinhibition by diminishing the inhibitory transmission via upregulation of α1 subunit and downregulation of γ2 subunits. GPR30 also facilitated excitatory transmission by promoting functional up-regulation of the calcium/calmodulin-dependent protein kinase II α (CaMKII α) in glutamatergic neurons and increasing the clustering of the glutamate receptor subunit 1 (GluR1) subunit to excitatory synapse. Taken together, GPR30 contributed to the development of BCP by both facilitating excitatory transmission and inhibiting inhibitory transmission in the spinal cord. Our findings provide the new spinal disinhibition and sensitivity mechanisms underlying the development of bone cancer pain." @default.
• W2519463942 created "2016-09-23" @default.
• W2519463942 creator A5000926904 @default.
• W2519463942 creator A5001553979 @default.
• W2519463942 creator A5010424603 @default.
• W2519463942 creator A5017525445 @default.
• W2519463942 creator A5018324791 @default.
• W2519463942 creator A5031446454 @default.
• W2519463942 creator A5037316994 @default.
• W2519463942 creator A5062662220 @default.
• W2519463942 creator A5067095480 @default.
• W2519463942 creator A5069772311 @default.
• W2519463942 date "2016-09-06" @default.
• W2519463942 modified "2023-09-30" @default.
• W2519463942 title "GPR30 disrupts the balance of GABAergic and glutamatergic transmission in the spinal cord driving to the development of bone cancer pain" @default.
• W2519463942 cites W1567615855 @default.
• W2519463942 cites W1896223819 @default.
• W2519463942 cites W1945096581 @default.
• W2519463942 cites W1972211929 @default.
• W2519463942 cites W1977520596 @default.
• W2519463942 cites W1980369017 @default.
• W2519463942 cites W1988722797 @default.
• W2519463942 cites W1991925106 @default.
• W2519463942 cites W1995414363 @default.
• W2519463942 cites W1997185390 @default.
• W2519463942 cites W2003754617 @default.
• W2519463942 cites W2008570007 @default.
• W2519463942 cites W2009947099 @default.
• W2519463942 cites W2011831455 @default.
• W2519463942 cites W2012935976 @default.
• W2519463942 cites W2013960132 @default.
• W2519463942 cites W2034776651 @default.
• W2519463942 cites W2039403600 @default.
• W2519463942 cites W2043812087 @default.
• W2519463942 cites W2047354859 @default.
• W2519463942 cites W2048112347 @default.
• W2519463942 cites W2050243692 @default.
• W2519463942 cites W2058470031 @default.
• W2519463942 cites W2059055079 @default.
• W2519463942 cites W2063223361 @default.
• W2519463942 cites W2071561670 @default.
• W2519463942 cites W2078275530 @default.
• W2519463942 cites W2087191156 @default.
• W2519463942 cites W2087324367 @default.
• W2519463942 cites W2093385793 @default.
• W2519463942 cites W2101934635 @default.
• W2519463942 cites W2105330716 @default.
• W2519463942 cites W2107783538 @default.
• W2519463942 cites W2120770581 @default.
• W2519463942 cites W2140179339 @default.
• W2519463942 cites W2163508877 @default.
• W2519463942 cites W2171381392 @default.
• W2519463942 doi "https://doi.org/10.18632/oncotarget.11867" @default.
• W2519463942 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5341991" @default.
• W2519463942 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27608844" @default.
• W2519463942 hasPublicationYear "2016" @default.
• W2519463942 type Work @default.
• W2519463942 sameAs 2519463942 @default.
• W2519463942 citedByCount "9" @default.
• W2519463942 countsByYear W25194639422017 @default.
• W2519463942 countsByYear W25194639422019 @default.
• W2519463942 countsByYear W25194639422021 @default.
• W2519463942 countsByYear W25194639422022 @default.
• W2519463942 countsByYear W25194639422023 @default.
• W2519463942 crossrefType "journal-article" @default.
• W2519463942 hasAuthorship W2519463942A5000926904 @default.
• W2519463942 hasAuthorship W2519463942A5001553979 @default.
• W2519463942 hasAuthorship W2519463942A5010424603 @default.
• W2519463942 hasAuthorship W2519463942A5017525445 @default.
• W2519463942 hasAuthorship W2519463942A5018324791 @default.
• W2519463942 hasAuthorship W2519463942A5031446454 @default.
• W2519463942 hasAuthorship W2519463942A5037316994 @default.
• W2519463942 hasAuthorship W2519463942A5062662220 @default.
• W2519463942 hasAuthorship W2519463942A5067095480 @default.
• W2519463942 hasAuthorship W2519463942A5069772311 @default.
• W2519463942 hasBestOaLocation W25194639421 @default.
• W2519463942 hasConcept C104317684 @default.
• W2519463942 hasConcept C118552586 @default.
• W2519463942 hasConcept C121608353 @default.
• W2519463942 hasConcept C126322002 @default.
• W2519463942 hasConcept C127561419 @default.
• W2519463942 hasConcept C185592680 @default.
• W2519463942 hasConcept C2776035513 @default.
• W2519463942 hasConcept C2778904085 @default.
• W2519463942 hasConcept C2780775167 @default.
• W2519463942 hasConcept C55493867 @default.
• W2519463942 hasConcept C71924100 @default.
• W2519463942 hasConcept C98274493 @default.
• W2519463942 hasConceptScore W2519463942C104317684 @default.
• W2519463942 hasConceptScore W2519463942C118552586 @default.
• W2519463942 hasConceptScore W2519463942C121608353 @default.
• W2519463942 hasConceptScore W2519463942C126322002 @default.
• W2519463942 hasConceptScore W2519463942C127561419 @default.
• W2519463942 hasConceptScore W2519463942C185592680 @default.
• W2519463942 hasConceptScore W2519463942C2776035513 @default.
• W2519463942 hasConceptScore W2519463942C2778904085 @default.
• W2519463942 hasConceptScore W2519463942C2780775167 @default.
• W2519463942 hasConceptScore W2519463942C55493867 @default.

• next